Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Hall currently holds 4,826 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Hall has been a net seller of VRX stock. They have purchased $55.4K and sold $878.5K worth of shares.
Susan Hall's most recent insider trade was on Mar 11, 2016, when they sold 626 shares at $41.67 per share.
Susan Hall serves as Executive at Valeant Pharmaceuticals International, Inc. (VRX). They have executed 19 insider transactions totaling $933.9K over their tenure at the company.
Susan Hall holds the position of Executive at Valeant Pharmaceuticals International, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Susan Hall has shown a selling trading pattern, with $55.4K in total purchases and $878.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susan Hall was on Mar 7, 2012, when they sold $878.5K worth of VRX shares. This transaction involved 16,120 shares at $54.50 per share.
Susan Hall currently owns 4,826 shares of Valeant Pharmaceuticals International, Inc. (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Hall's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Hall has 19 Form 4 filings on record as an insider at Valeant Pharmaceuticals International, Inc..
Set alerts for Susan Hall and 40,000+ other insiders.